866-997-4948(US-Canada Toll Free)

Global Active Pharmaceutical Ingredient Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Aug 2018

Category :

Pharmaceutical

No. of Pages : 127 Pages

This report studies the global market size of Active Pharmaceutical Ingredient in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Active Pharmaceutical Ingredient in these regions.
This research report categorizes the global Active Pharmaceutical Ingredient market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Active Pharmaceutical Ingredient market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Active Pharmaceutical Ingredient market based on company, product type, application and key regions.

The various contributors involved in the value chain of Active Pharmaceutical Ingredient include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Active Pharmaceutical Ingredient include
Teva
Novartis
Pfizer
Johnson & Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddys Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
Cipla
Tian Yao
Lupin
North East Pharmaceutical
Albemarle
Shandong Lukang Pharmaceutical
JiangsuHengrui Medicine

Market Size Split by Type
Synthetic API
Biotech API
Other
Market Size Split by Application
Chemical
Deodorant
Dailylife

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Active Pharmaceutical Ingredient market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Active Pharmaceutical Ingredient market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Active Pharmaceutical Ingredient manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Active Pharmaceutical Ingredient with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Active Pharmaceutical Ingredient submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Active Pharmaceutical Ingredient are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Active Pharmaceutical Ingredient market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Active Pharmaceutical Ingredient Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Active Pharmaceutical Ingredient Market Size Growth Rate by Type
1.4.2 Synthetic API
1.4.3 Biotech API
1.4.4 Other
1.5 Market by Application
1.5.1 Global Active Pharmaceutical Ingredient Market Size Growth Rate by Application
1.5.2 Chemical
1.5.3 Deodorant
1.5.4 Dailylife
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Active Pharmaceutical Ingredient Market Size
2.1.1 Global Active Pharmaceutical Ingredient Revenue 2016-2025
2.1.2 Global Active Pharmaceutical Ingredient Sales 2016-2025
2.2 Active Pharmaceutical Ingredient Growth Rate by Regions
2.2.1 Global Active Pharmaceutical Ingredient Sales by Regions
2.2.2 Global Active Pharmaceutical Ingredient Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Active Pharmaceutical Ingredient Sales by Manufacturers
3.1.1 Active Pharmaceutical Ingredient Sales by Manufacturers
3.1.2 Active Pharmaceutical Ingredient Sales Market Share by Manufacturers
3.1.3 Global Active Pharmaceutical Ingredient Market Concentration Ratio (CR5 and HHI)
3.2 Active Pharmaceutical Ingredient Revenue by Manufacturers
3.2.1 Active Pharmaceutical Ingredient Revenue by Manufacturers (2016-2018)
3.2.2 Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2016-2018)
3.3 Active Pharmaceutical Ingredient Price by Manufacturers
3.4 Active Pharmaceutical Ingredient Manufacturing Base Distribution, Product Types
3.4.1 Active Pharmaceutical Ingredient Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Active Pharmaceutical Ingredient Product Category
3.4.3 Date of International Manufacturers Enter into Active Pharmaceutical Ingredient Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Active Pharmaceutical Ingredient Sales by Type
4.2 Global Active Pharmaceutical Ingredient Revenue by Type
4.3 Active Pharmaceutical Ingredient Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Active Pharmaceutical Ingredient Breakdown Data by Application

6 North America
6.1 North America Active Pharmaceutical Ingredient by Countries
6.1.1 North America Active Pharmaceutical Ingredient Sales by Countries
6.1.2 North America Active Pharmaceutical Ingredient Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Active Pharmaceutical Ingredient by Type
6.3 North America Active Pharmaceutical Ingredient by Application
6.4 North America Active Pharmaceutical Ingredient by Company

7 Europe
7.1 Europe Active Pharmaceutical Ingredient by Countries
7.1.1 Europe Active Pharmaceutical Ingredient Sales by Countries
7.1.2 Europe Active Pharmaceutical Ingredient Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Active Pharmaceutical Ingredient by Type
7.3 Europe Active Pharmaceutical Ingredient by Application
7.4 Europe Active Pharmaceutical Ingredient by Company

8 Asia Pacific
8.1 Asia Pacific Active Pharmaceutical Ingredient by Countries
8.1.1 Asia Pacific Active Pharmaceutical Ingredient Sales by Countries
8.1.2 Asia Pacific Active Pharmaceutical Ingredient Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Active Pharmaceutical Ingredient by Type
8.3 Asia Pacific Active Pharmaceutical Ingredient by Application
8.4 Asia Pacific Active Pharmaceutical Ingredient by Company

9 Central & South America
9.1 Central & South America Active Pharmaceutical Ingredient by Countries
9.1.1 Central & South America Active Pharmaceutical Ingredient Sales by Countries
9.1.2 Central & South America Active Pharmaceutical Ingredient Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Active Pharmaceutical Ingredient by Type
9.3 Central & South America Active Pharmaceutical Ingredient by Application
9.4 Central & South America Active Pharmaceutical Ingredient by Company

10 Middle East and Africa
10.1 Middle East and Africa Active Pharmaceutical Ingredient by Countries
10.1.1 Middle East and Africa Active Pharmaceutical Ingredient Sales by Countries
10.1.2 Middle East and Africa Active Pharmaceutical Ingredient Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Active Pharmaceutical Ingredient by Type
10.3 Middle East and Africa Active Pharmaceutical Ingredient by Application
10.4 Middle East and Africa Active Pharmaceutical Ingredient by Company

11 Company Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Active Pharmaceutical Ingredient
11.1.4 Active Pharmaceutical Ingredient Product Description
11.1.5 Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Active Pharmaceutical Ingredient
11.2.4 Active Pharmaceutical Ingredient Product Description
11.2.5 Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Active Pharmaceutical Ingredient
11.3.4 Active Pharmaceutical Ingredient Product Description
11.3.5 Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Active Pharmaceutical Ingredient
11.4.4 Active Pharmaceutical Ingredient Product Description
11.4.5 Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Active Pharmaceutical Ingredient
11.5.4 Active Pharmaceutical Ingredient Product Description
11.5.5 Recent Development
11.6 North China Pharmaceutical Group
11.6.1 North China Pharmaceutical Group Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Active Pharmaceutical Ingredient
11.6.4 Active Pharmaceutical Ingredient Product Description
11.6.5 Recent Development
11.7 Dr. Reddys Laboratories
11.7.1 Dr. Reddys Laboratories Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Active Pharmaceutical Ingredient
11.7.4 Active Pharmaceutical Ingredient Product Description
11.7.5 Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Active Pharmaceutical Ingredient
11.8.4 Active Pharmaceutical Ingredient Product Description
11.8.5 Recent Development
11.9 Aurobindo pharma
11.9.1 Aurobindo pharma Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Active Pharmaceutical Ingredient
11.9.4 Active Pharmaceutical Ingredient Product Description
11.9.5 Recent Development
11.10 Sun Pharmaceutical Industries
11.10.1 Sun Pharmaceutical Industries Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Active Pharmaceutical Ingredient
11.10.4 Active Pharmaceutical Ingredient Product Description
11.10.5 Recent Development
11.11 Boehringer Ingelheim GmbH
11.12 Bayer
11.13 BASF
11.14 DSM
11.15 Zhejiang Medicine
11.16 Biocon
11.17 Johnson Matthey
11.18 Hisun Pharmacy
11.19 Cambrex
11.20 Shandong Xinhua Pharmaceutical
11.21 Lonza group
11.22 Huahai Pharmaceutical
11.23 Haerbin Pharmaceutical Group
11.24 Cipla
11.25 Tian Yao
11.26 Lupin
11.27 North East Pharmaceutical
11.28 Albemarle
11.29 Shandong Lukang Pharmaceutical
11.30 JiangsuHengrui Medicine

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Active Pharmaceutical Ingredient Raw Material
13.1.2 Active Pharmaceutical Ingredient Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Active Pharmaceutical Ingredient
Figure Global Active Pharmaceutical Ingredient Production (K MT) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Active Pharmaceutical Ingredient Production Market Share by Types (Product Category) in 2017
Figure Synthetic API Product Picture
Table Major Manufacturers of Synthetic API
Figure Biotech API Product Picture
Table Major Manufacturers of Biotech API
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global Active Pharmaceutical Ingredient Market Size Growth Rate by Application 2018-2025 (K MT)
Figure Chemical
Figure Deodorant
Figure Dailylife
Figure Active Pharmaceutical Ingredient Report Years Considered
Figure Global Active Pharmaceutical Ingredient Market Size 2016-2025 (Million US$)
Figure Global Active Pharmaceutical Ingredient Sales 2016-2025 (K MT)
Table Global Active Pharmaceutical Ingredient Market Size by Regions 2016-2025 (K MT) & (Million US$)
Table Global Active Pharmaceutical Ingredient Sales by Regions 2016-2025 (K MT)
Table Global Active Pharmaceutical Ingredient Sales Market Share by Regions 2016-2025
Figure Global Active Pharmaceutical Ingredient Sales Market Share by Regions 2016-2025
Figure 2017 Global Active Pharmaceutical Ingredient Sales Market Share by Regions
Table Global Active Pharmaceutical Ingredient Revenue by Regions 2016-2025 (Million US$)
Table Global Active Pharmaceutical Ingredient Revenue Market Share by Regions 2016-2025
Figure Global Active Pharmaceutical Ingredient Revenue Market Share by Regions 2016-2025
Figure 2017 Global Active Pharmaceutical Ingredient Revenue Market Share by Regions
Table Global Active Pharmaceutical Ingredient Sales by Manufacturers (2016-2018) (K MT)
Table Global Active Pharmaceutical Ingredient Sales Share by Manufacturers (2016-2018)
Figure Global Active Pharmaceutical Ingredient Sales Share by Manufacturers in 2017
Table Active Pharmaceutical Ingredient Revenue by Manufacturers (2016-2018) (Million US$)
Table Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2016-2018)
Figure Active Pharmaceutical Ingredient Value Share by Manufacturers in 2017
Table Global Active Pharmaceutical Ingredient Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Active Pharmaceutical Ingredient Price (2016-2018) (USD/MT)
Table Active Pharmaceutical Ingredient Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Active Pharmaceutical Ingredient Product Category
Table Date of International Manufacturers Enter into Active Pharmaceutical Ingredient Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Active Pharmaceutical Ingredient Sales by Type (2016-2025) (K MT)
Table Global Active Pharmaceutical Ingredient Sales Share by Type (2016-2025)
Figure Global Active Pharmaceutical Ingredient Sales Market Share by Type (2016-2025)
Figure Global Active Pharmaceutical Ingredient Sales Market Share by Type in 2017
Table Global Active Pharmaceutical Ingredient Revenue by Type (2016-2025) (Million US$)
Table Global Active Pharmaceutical Ingredient Revenue Share by Type (2016-2025)
Figure Global Active Pharmaceutical Ingredient Revenue Market Share by Type (2016-2025)
Figure Global Active Pharmaceutical Ingredient Revenue Market Share by Type in 2017
Table Active Pharmaceutical Ingredient Price by Type 2013-2018 (USD/MT)
Table Global Active Pharmaceutical Ingredient Sales by Application (2016-2025) (K MT)
Table Global Active Pharmaceutical Ingredient Sales Share by Application (2016-2025)
Figure Global Sales Active Pharmaceutical Ingredient Market Share by Application (2016-2025)
Figure Global Sales Active Pharmaceutical Ingredient Market Share by Application (2016-2025)
Figure North America Active Pharmaceutical Ingredient Sales Growth Rate 2016-2025 (K MT)
Figure North America Active Pharmaceutical Ingredient Revenue Growth Rate 2016-2025 (Million US$)
Table North America Active Pharmaceutical Ingredient Sales by Countries (2016-2025) (K MT)
Table North America Active Pharmaceutical Ingredient Sales Market Share by Countries (2016-2025)
Figure 2017 North America Active Pharmaceutical Ingredient Sales Market Share by Countries
Table North America Active Pharmaceutical Ingredient Revenue by Countries (2016-2025) (Million US$)
Table North America Active Pharmaceutical Ingredient Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Active Pharmaceutical Ingredient Revenue Market Share by Countries
Figure United States Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure United States Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure Canada Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure Mexico Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (Million US$)
Table North America Active Pharmaceutical Ingredient Sales by Type (2016-2025) (K MT)
Table North America Active Pharmaceutical Ingredient Sales Market Share by Type (2016-2025)
Figure 2017 North America Active Pharmaceutical Ingredient Market Share by Type
Table North America Active Pharmaceutical Ingredient Sales by Application (2016-2025) (K MT)
Table North America Active Pharmaceutical Ingredient Sales Market Share by Application (2016-2025)
Figure 2017 North America Active Pharmaceutical Ingredient Market Share by Application
Table North America Active Pharmaceutical Ingredient Sales by Company (2016-2018) (K MT)
Table North America Active Pharmaceutical Ingredient Sales Market Share by Company (2016-2018)
Figure North America Active Pharmaceutical Ingredient Sales Market Share by Company in 2017
Figure Europe Active Pharmaceutical Ingredient Sales Growth Rate 2016-2025 (K MT)
Figure Europe Active Pharmaceutical Ingredient Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Active Pharmaceutical Ingredient Sales by Countries (2016-2025) (K MT)
Table Europe Active Pharmaceutical Ingredient Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Active Pharmaceutical Ingredient Sales Market Share by Countries
Table Europe Active Pharmaceutical Ingredient Revenue by Countries (2016-2025) (Million US$)
Table Europe Active Pharmaceutical Ingredient Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Active Pharmaceutical Ingredient Revenue Market Share by Countries
Figure Germany Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure Germany Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (K MT)
Figure France Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure France Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (K MT)
Figure UK Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure UK Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure Italy Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure Russia Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Active Pharmaceutical Ingredient Sales by Type (2016-2025) (K MT)
Table Europe Active Pharmaceutical Ingredient Sales Market Share by Type (2016-2025)
Figure 2017 Europe Active Pharmaceutical Ingredient Market Share by Type
Table Europe Active Pharmaceutical Ingredient Sales by Application (2016-2025) (K MT)
Table Europe Active Pharmaceutical Ingredient Sales Market Share by Application (2016-2025)
Figure 2017 Europe Active Pharmaceutical Ingredient Market Share by Application
Table Europe Active Pharmaceutical Ingredient Sales by Company (2016-2018) (K MT)
Table Europe Active Pharmaceutical Ingredient Sales Market Share by Company (2016-2018)
Figure Europe Active Pharmaceutical Ingredient Sales Market Share by Company in 2017
Figure Asia Pacific Active Pharmaceutical Ingredient Sales Growth Rate 2016-2025 (K MT)
Figure Asia Pacific Active Pharmaceutical Ingredient Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Active Pharmaceutical Ingredient Sales by Countries (2016-2025) (K MT)
Table Asia Pacific Active Pharmaceutical Ingredient Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Active Pharmaceutical Ingredient Sales Market Share by Countries
Table Asia Pacific Active Pharmaceutical Ingredient Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Active Pharmaceutical Ingredient Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Active Pharmaceutical Ingredient Revenue Market Share by Countries
Figure China Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure China Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure Japan Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure Korea Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (Million US$)
Figure India Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure India Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure Australia Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure Indonesia Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure Malaysia Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure Philippines Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure Thailand Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure Vietnam Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure Singapore Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Active Pharmaceutical Ingredient Sales by Type (2016-2025) (K MT)
Table Asia Pacific Active Pharmaceutical Ingredient Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Active Pharmaceutical Ingredient Market Share by Type
Table Asia Pacific Active Pharmaceutical Ingredient Sales by Application (2016-2025) (K MT)
Table Asia Pacific Active Pharmaceutical Ingredient Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Active Pharmaceutical Ingredient Market Share by Application
Table Asia Pacific Active Pharmaceutical Ingredient Sales by Company (2016-2018) (K MT)
Table Asia Pacific Active Pharmaceutical Ingredient Sales Market Share by Company (2016-2018)
Figure Asia Pacific Active Pharmaceutical Ingredient Sales Market Share by Company in 2017
Figure Central & South America Active Pharmaceutical Ingredient Sales Growth Rate 2016-2025 (K MT)
Figure Central & South America Active Pharmaceutical Ingredient Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Active Pharmaceutical Ingredient Sales by Countries (2016-2025) (K MT)
Table Central & South America Active Pharmaceutical Ingredient Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Active Pharmaceutical Ingredient Sales Market Share by Countries
Table Central & South America Active Pharmaceutical Ingredient Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Active Pharmaceutical Ingredient Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Active Pharmaceutical Ingredient Revenue Market Share by Countries
Figure Brazil Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure Brazil Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure Argentina Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Active Pharmaceutical Ingredient Sales by Type (2016-2025) (K MT)
Table Central & South America Active Pharmaceutical Ingredient Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Active Pharmaceutical Ingredient Market Share by Type
Table Central & South America Active Pharmaceutical Ingredient Sales by Application (2016-2025) (K MT)
Table Central & South America Active Pharmaceutical Ingredient Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Active Pharmaceutical Ingredient Market Share by Application
Table Central & South America Active Pharmaceutical Ingredient Sales by Company (2016-2018) (K MT)
Table Central & South America Active Pharmaceutical Ingredient Sales Market Share by Company (2016-2018)
Figure Central & South America Active Pharmaceutical Ingredient Sales Market Share by Company in 2017
Figure Middle East and Africa Active Pharmaceutical Ingredient Sales Growth Rate 2016-2025 (K MT)
Figure Middle East and Africa Active Pharmaceutical Ingredient Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Active Pharmaceutical Ingredient Sales by Countries (2016-2025) (K MT)
Table Middle East and Africa Active Pharmaceutical Ingredient Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Active Pharmaceutical Ingredient Sales Market Share by Countries
Table Middle East and Africa Active Pharmaceutical Ingredient Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Active Pharmaceutical Ingredient Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Active Pharmaceutical Ingredient Revenue Market Share by Countries
Figure GCC Countries Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure GCC Countries Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure Turkey Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure Egypt Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Active Pharmaceutical Ingredient Sales Growth Rate (2016-2025) (K MT)
Figure South Africa Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Active Pharmaceutical Ingredient Sales by Type (2016-2025) (K MT)
Table Middle East and Africa Active Pharmaceutical Ingredient Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Active Pharmaceutical Ingredient Market Share by Type
Table Middle East and Africa Active Pharmaceutical Ingredient Sales by Application (2016-2025) (K MT)
Table Middle East and Africa Active Pharmaceutical Ingredient Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Active Pharmaceutical Ingredient Market Share by Application
Table Middle East and Africa Active Pharmaceutical Ingredient Sales by Company (2016-2018) (K MT)
Table Middle East and Africa Active Pharmaceutical Ingredient Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Active Pharmaceutical Ingredient Sales Market Share by Company in 2017
Table Teva Company Details
Table Teva Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Teva Recent Development
Table Novartis Company Details
Table Novartis Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Johnson & Johnson Recent Development
Table Mylan Company Details
Table Mylan Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Mylan Recent Development
Table North China Pharmaceutical Group Company Details
Table North China Pharmaceutical Group Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table North China Pharmaceutical Group Recent Development
Table Dr. Reddys Laboratories Company Details
Table Dr. Reddys Laboratories Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Dr. Reddys Laboratories Recent Development
Table Roche Company Details
Table Roche Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Roche Recent Development
Table Aurobindo pharma Company Details
Table Aurobindo pharma Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Aurobindo pharma Recent Development
Table Sun Pharmaceutical Industries Company Details
Table Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Sun Pharmaceutical Industries Recent Development
Table Boehringer Ingelheim GmbH Company Details
Table Bayer Company Details
Table BASF Company Details
Table DSM Company Details
Table Zhejiang Medicine Company Details
Table Biocon Company Details
Table Johnson Matthey Company Details
Table Hisun Pharmacy Company Details
Table Cambrex Company Details
Table Shandong Xinhua Pharmaceutical Company Details
Table Lonza group Company Details
Table Huahai Pharmaceutical Company Details
Table Haerbin Pharmaceutical Group Company Details
Table Cipla Company Details
Table Tian Yao Company Details
Table Lupin Company Details
Table North East Pharmaceutical Company Details
Table Albemarle Company Details
Table Shandong Lukang Pharmaceutical Company Details
Table JiangsuHengrui Medicine Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Active Pharmaceutical Ingredient Value Chain
Table Typical Suppliers of Key Active Pharmaceutical Ingredient Raw Material
Table Active Pharmaceutical Ingredient Customers List
Table Active Pharmaceutical Ingredient Sales Channels
Table Active Pharmaceutical Ingredient Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *